Coloplast A/S is a global medical technology company specializing in intimate healthcare products and services. The company's business model is centered on developing, manufacturing, and marketing disposable medical devices for chronic conditions, which generates a recurring revenue stream as products are typically used daily over long periods. Coloplast operates through five main business segments: Ostomy Care (approximately 35% of revenue), which provides bags and accessories for individuals with a stoma; Continence Care (approximately 32%), offering intermittent catheters and bowel management systems; Advanced Wound Care (approximately 15%), which includes advanced wound dressings and the Kerecis fish-skin biologic technology; Interventional Urology (approximately 10%), providing surgical devices for urological and gynecological disorders; and Voice & Respiratory Care (approximately 8%), which offers products for laryngectomy and tracheostomy patients following the acquisition of Atos Medical. Geographically, Coloplast generates the majority of its sales in Europe, followed by North America and emerging markets. The company maintains a competitive position with a significant market share in ostomy and continence care, driven by continuous product development, direct-to-consumer services, and strategic acquisitions to expand its therapeutic footprint.
